A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis.
<h4>Introduction</h4>New Onset Atrial Fibrillation (NOAF) is the most common arrhythmia in intensive care. Complications of NOAF include thromboembolic events such as myocardial infarction and stroke, which contribute to a greater risk of mortality. Inflammatory and coagulation biomarker...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0318365 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1825206822653394944 |
---|---|
author | Brian W Johnston Michael Downes Angela Hall Zachary Thomas Ingeborg D Welters |
author_facet | Brian W Johnston Michael Downes Angela Hall Zachary Thomas Ingeborg D Welters |
author_sort | Brian W Johnston |
collection | DOAJ |
description | <h4>Introduction</h4>New Onset Atrial Fibrillation (NOAF) is the most common arrhythmia in intensive care. Complications of NOAF include thromboembolic events such as myocardial infarction and stroke, which contribute to a greater risk of mortality. Inflammatory and coagulation biomarkers in sepsis are thought to be associated with NOAF development. The aim of this systematic review and narrative synthesis is to identify inflammatory and coagulation biomarkers as predisposing risk factors for NOAF in sepsis.<h4>Methods</h4>Three databases (Medline, Cochrane Library, and Scopus) were searched using a predefined search strategy. Inclusion / exclusion criteria were applied, and quality assessments were performed using the Newcastle Ottawa Scale (NOS).<h4>Results</h4>We identified 1776 articles; and 12 articles were included in this review. 8 articles were retrospective observational studies and 4 were prospective observational studies. There was considerable heterogeneity between studies regarding outcomes, methodological design, quality, definitions and reported biomarkers of interest. There is evidence that C-reactive protein (CRP) is associated with NOAF, with hazard ratios 3.33 (3.32-3.35) p = 0.001 and odds ratios of 1.011 (1.008-1.014) p<0.001. International Normalised Ratio (INR) and fibrinogen may be associated with NOAF with odds ratios reported as 1.837 (1.270-2.656) p = 0.001 and 1.535(1.232-1.914) p<0.001 respectively.<h4>Conclusion</h4>Further research is required to confirm the association between inflammatory and coagulation biomarkers and the development of NOAF in sepsis. A broader evidence base will guide treatment strategies, improving the standard of care for patients who develop NOAF in sepsis. Furthermore, given the heterogeneity between studies consideration should be given to inclusion of immune biomarkers in future core outcome sets for trials investigating NOAF. |
format | Article |
id | doaj-art-c924a042350d44a39d8684888c9ce870 |
institution | Kabale University |
issn | 1932-6203 |
language | English |
publishDate | 2025-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj-art-c924a042350d44a39d8684888c9ce8702025-02-07T05:30:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01201e031836510.1371/journal.pone.0318365A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis.Brian W JohnstonMichael DownesAngela HallZachary ThomasIngeborg D Welters<h4>Introduction</h4>New Onset Atrial Fibrillation (NOAF) is the most common arrhythmia in intensive care. Complications of NOAF include thromboembolic events such as myocardial infarction and stroke, which contribute to a greater risk of mortality. Inflammatory and coagulation biomarkers in sepsis are thought to be associated with NOAF development. The aim of this systematic review and narrative synthesis is to identify inflammatory and coagulation biomarkers as predisposing risk factors for NOAF in sepsis.<h4>Methods</h4>Three databases (Medline, Cochrane Library, and Scopus) were searched using a predefined search strategy. Inclusion / exclusion criteria were applied, and quality assessments were performed using the Newcastle Ottawa Scale (NOS).<h4>Results</h4>We identified 1776 articles; and 12 articles were included in this review. 8 articles were retrospective observational studies and 4 were prospective observational studies. There was considerable heterogeneity between studies regarding outcomes, methodological design, quality, definitions and reported biomarkers of interest. There is evidence that C-reactive protein (CRP) is associated with NOAF, with hazard ratios 3.33 (3.32-3.35) p = 0.001 and odds ratios of 1.011 (1.008-1.014) p<0.001. International Normalised Ratio (INR) and fibrinogen may be associated with NOAF with odds ratios reported as 1.837 (1.270-2.656) p = 0.001 and 1.535(1.232-1.914) p<0.001 respectively.<h4>Conclusion</h4>Further research is required to confirm the association between inflammatory and coagulation biomarkers and the development of NOAF in sepsis. A broader evidence base will guide treatment strategies, improving the standard of care for patients who develop NOAF in sepsis. Furthermore, given the heterogeneity between studies consideration should be given to inclusion of immune biomarkers in future core outcome sets for trials investigating NOAF.https://doi.org/10.1371/journal.pone.0318365 |
spellingShingle | Brian W Johnston Michael Downes Angela Hall Zachary Thomas Ingeborg D Welters A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis. PLoS ONE |
title | A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis. |
title_full | A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis. |
title_fullStr | A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis. |
title_full_unstemmed | A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis. |
title_short | A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis. |
title_sort | systematic review on the influence of coagulopathy and immune activation on new onset atrial fibrillation in patients with sepsis |
url | https://doi.org/10.1371/journal.pone.0318365 |
work_keys_str_mv | AT brianwjohnston asystematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis AT michaeldownes asystematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis AT angelahall asystematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis AT zacharythomas asystematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis AT ingeborgdwelters asystematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis AT brianwjohnston systematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis AT michaeldownes systematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis AT angelahall systematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis AT zacharythomas systematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis AT ingeborgdwelters systematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis |